Intra-Cellular, Takeda deal

Intra-Cellular and Takeda mutually terminated a 2011 deal granting the pharma worldwide rights to develop and commercialize Intra-Cellular’s phosphodiesterase-1 (PDE-1) inhibitors. The biotech declin...